Stock Exchange: On the Helsinki Stock Exchange, the worst decline in the evening – BioReTec rising rising

February of the Helsinki Stock Exchange OMXH General Index began in a fall in a decline with geopolitical worries. On Monday afternoon, the general index had been pushing the morning reading briskly upwards, ending up by about 0.9 % at 9,952.83.

A total of six percent was registered for the end of January.

The United States gave Mexico, Canada and China import duties on Saturday. Already on Monday afternoon, it was reported that duties against Mexico are being postponed for a month Donald Trump to be discussed by the Mexican President Claudia Sheinbaumin with. In the market, it aroused hope that a similar turn is seen with Canada.

The Helsinki Stock Exchange was down almost the top of the most replaced shares. Nokia struck upstream of 0.1 percent rising and Fortum To an increase of 0.6 %.

Profit warnings and marketing authorization

Health technology company Bioretec He announced last Friday evening that its Remeos traumatic screw product family received a CE approval, allowing for product launch to Europe.

“We are very pleased that the EU marketing authorization covers all models and extensive applications. We can now immediately start providing patients to patients throughout Europe, ”CEO of Biotetec Alan Donze stated.

According to him, obtaining permission also offers access to non-European markets that recognize the CE character approval, and the permit enables the collection of clinical evidence.

“This display contributes to expanding applications in the United States, where our current sales license is more limited.”

Biotec’s stock would shoot at the top of the ascenders on Monday. The share was 28.6 % rising.

Consulting firm Dovre Group Raised its profit guidance for last year.

Dovre Group’s net sales are now expected to be approximately EUR 99 million and operating profit (EBIT) at about EUR 12 million at a loss last year. According to the guidelines last December, Dovre’s net sales in 2024 were expected to be between EUR 88 and 93 million and operating profit between -13 and -15 million. In December, Dovre’s profit warning was negative.

According to Dovre, the guideline is due to the faster progress than the projects of Suvic, a wind power design company Suvic.

Dovre’s share rose 2.8 percent.

The construction consulting company that has warned the profit -warning industry over the weekend Solwers was 12.6 percent down. Based on preliminary and non -audit information, it anticipates that the IFRS EBIT business in the Group’s last quarter of 2024 will remain close to zero.

No interim reports received on Monday of the lively earnings week, but later this week get tens of.